mechanism 2,744 words KG: ent-gene-79331cb0
Contents

GRN Progranulin FTD Causal Chain

🔬 Protein Info
Gene Symbolent-gene-79331cb0
FunctionProgranulin Haploinsufficiency
KG Connections3 knowledge graph edges
DatabasesGeneCardsUniProtNCBI GeneHPASTRING

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (24)

TREM2-mediated microglial tau clearance enhancement
Score: 0.62
Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.70
Microglial Purinergic Reprogramming
Score: 0.70
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
Cryptic Exon Silencing Restoration
Score: 0.53
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.76
Cross-Seeding Prevention Strategy
Score: 0.69
Glycine-Rich Domain Competitive Inhibition
Score: 0.64
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
Targeted Butyrate Supplementation for Microglial Phenotype M
Score: 0.70
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.72
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76
APOE Isoform Expression Across Glial Subtypes
Score: 0.74
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
APOE-TREM2 Interaction Modulation
Score: 0.74
Astrocyte-Mediated Neuronal Epigenetic Rescue
Score: 0.73
APOE Isoform Conversion Therapy
Score: 0.72
pg 1/2Next →

Related Analyses (30)

RNA binding protein dysregulation across ALS FTD AD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived

Related Experiments (21)

Presymptomatic GRN Carrier Intervention Timing — Biomarker-G
clinical · proposed · Score: 0.40
TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an
validation · proposed · Score: 0.40
TDP-43 PET Ligand Development for FTD and ALS
clinical · proposed · Score: 0.40
Mechanism: Progranulin Loss and TDP-43 Pathology in FTD
validation · proposed · Score: 0.40
Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.40

Knowledge Graph (3 edges)

h-4814bca81e targets ent-gene-79331cb0
ent-gene-79331cb0 targeted_by h-4814bca81e
ent-gene-79331cb0 participates_in_pathway R-HSA-6798695

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.